Monografie
T cell Re-direction against Glypican-3 for Immunotherapy of Hepatocellular Carcinoma
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Diss., 2015
- Identifier
-
1076124925
- Thema
-
Krebs; Onkologie; Hochschulschrift
- Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Dargel, Christina
- Protzer-Knolle, Ulrike
- Durner, Jörg
Ähnliche Objekte (12)
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
RIG-I-based immunotherapy of hepatocellular carcinoma : target validation and mechanisms of action in vivo
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
RIG-I-based immunotherapy of hepatocellular carcinoma : target validation and mechanisms of action in vivo
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma
Immunophenotyping of the hepatocellular carcinoma patients
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma
Subclinical hepatocellular carcinoma
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy
Early antibiotic exposure is not detrimental to therapeutic effect from immunotherapy in hepatocellular carcinoma
RIG-I-based immunotherapy of hepatocellular carcinoma : target validation and mechanisms of action in vivo
Targeting FUBP1 in Hepatocellular Carcinoma
Pathogenesis of human hepatocellular carcinoma
Multidisciplinary treatment of hepatocellular carcinoma
Targeting FUBP1 in hepatocellular carcinoma